Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Status
- RECRUITING
- Phase
- PHASE3
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
HDM201 Added to CT in R/R or Newly Diagnosed AML
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
- Status
- TERMINATED
- Phase
- PHASE1
Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2